Chemical inhibitors of 1110038F14Rik can be characterized by their ability to interrupt various signaling pathways and cellular processes that regulate the activity of this protein. Staurosporine is a potent kinase inhibitor and by inhibiting a broad spectrum of kinases, it can prevent the phosphorylation events necessary for the activation of proteins like 1110038F14Rik. Wortmannin and LY294002 both target PI3K, a key enzyme in the phosphatidylinositol signaling pathway. By inhibiting PI3K, these chemicals can attenuate the downstream signaling cascade, leading to a decrease in the activity of proteins that are regulated by this pathway, including 1110038F14Rik. Rapamycin, an mTOR inhibitor, disrupts the mTOR signaling pathway which is crucial for cell growth and proliferation, thereby potentially inhibiting the activity of proteins that are regulated by mTOR, including 1110038F14Rik.
Further, PD98059 and U0126 target MEK1/2, inhibiting the activation of the ERK pathway, which is involved in cell proliferation and survival. This inhibition can reduce the regulatory influence of the ERK pathway on 1110038F14Rik. Additionally, SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively, which are both involved in the response to cellular stress and inflammation. By inhibiting these kinases, the associated stress response pathways that may control 1110038F14Rik activity are also inhibited. PP2, through its inhibition of Src family kinases, can alter cell adhesion, growth, and differentiation signaling pathways, potentially leading to an inhibition of 1110038F14Rik activity. ZM-447439 targets Aurora kinases, which play a role in cell cycle progression, thus its inhibitory action can disrupt cell cycle-related pathways that may control 1110038F14Rik. Dasatinib, another inhibitor of Src family kinases as well as c-KIT, can interfere with multiple signaling pathways, potentially leading to a decrease in 1110038F14Rik activity. Lastly, Venetoclax inhibits Bcl-2, a key regulator of cell survival, and by this action, it can influence cell survival pathways that may regulate the activity of 1110038F14Rik, resulting in its functional inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits a broad range of kinases which may be involved in the phosphorylation that activates 1110038F14Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially reducing activation of downstream targets, including 1110038F14Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially reducing activation of downstream targets, including 1110038F14Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which is involved in signaling pathways that may regulate 1110038F14Rik activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1/2, potentially reducing ERK pathway signaling which may regulate 1110038F14Rik activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially reducing ERK pathway signaling which may regulate 1110038F14Rik activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially reducing signaling pathways that may regulate 1110038F14Rik activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially reducing signaling pathways that may regulate 1110038F14Rik activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, potentially affecting signaling pathways that may regulate 1110038F14Rik activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Inhibits Aurora kinases, potentially affecting cell cycle-related pathways that may regulate 1110038F14Rik. | ||||||